Slentrol

Withdrawn

This medicine's authorisation has been withdrawn

dirlotapide

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

Slentrol : EPAR - Summary for the public

Product information

Slentrol : EPAR - Product Information

Slentrol : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Slentrol
• Active substance:
  dirlotapide
• International non-proprietary name (INN) or common name:
  dirlotapide
• Species:
  Dogs
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

• EMA product number:
  EMEA/V/C/000116
• Marketing authorisation holder:
  Zoetis Belgium SA

  Rue Laid Burniat 1; 1348 Louvain-la-Neuve; Belgium

• Marketing authorisation issued:
  13/04/2007
• Revision:
  7

Assessment history

Changes since initial authorisation of medicine

Slentrol : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Slentrol : EPAR - Procedural steps taken before authorisation

Slentrol : EPAR - Scientific Discussion